Advertisement

Shanghai introduces facial recognition drug collection terminals to combat abuse by patients and pharmacists

  • New terminals being trialled at 31 health care organisations require people buying controlled medicines to verify their identities through face scans
  • The system is expected to prevent potential abusers from obtaining prescription medicines and turning them into materials for illegal drugs

Reading Time:2 minutes
Why you can trust SCMP
The new facial recognition system is expected to prevent potential abusers from obtaining prescription medicines and turning them into raw materials to produce illegal drugs such as crystal meth. File photo: AFP
Sarah Daiin Beijing

Shanghai has begun rolling out a drug collection terminal equipped with facial recognition technology for people buying certain medicines at pharmacies and hospitals in an effort to stem abuse.

Advertisement

At the new terminals, pharmacists and buyers of controlled medicines – such as those containing sedatives and psychotropic substances – will be asked to verify their identities by scanning their faces, according to local reports on Wednesday.

The system, which scans both pharmacists and patients, is designed to flag potential and high-risk abusers as well as prevent health care professionals from colluding to help patients illegally obtain drugs.

The move is expected to prevent potential abusers from obtaining prescription medicines containing ephedrine, psychotropic substances and tranquilisers and turning them into raw materials to produce illegal drugs – an increasing problem in China and the rest of the world, according to state news outlet China News Service. For instance, ephedrine or pseudoephedrine, commonly found in cold and allergy medications, is a key component of crystal meth.

Shanghai’s health care and anti-drug agencies have been testing the terminals since November and expect to achieve full coverage of all of the city’s medical institutions by the first half of next year, state-funded The Paper reported.

So far, the trial system has been adopted by 31 health care organisations across seven districts and performed more than 300 facial scans, according to China News.

Advertisement